Clinical Trial Update: Treatment Use of 3,4-Diaminopyridine

View source ↗

Summary

This clinical trial update discusses the use of 3,4-diaminopyridine for congenital myasthenic syndromes, noting that the study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Myasthenic Syndromes

Drugs mentioned

• 3,4-Diaminopyridine (3,4-diaminopyridine)

Snippet

Sponsor: Vern C. Juel, M.D. | Conditions: Myasthenic Syndromes, Congenital | Status: NO_LONGER_AVAILABLE